Why Private Equity Firms Need to Build a Global Capability Center
Control Towers, Not Cost Centers
By Robert Weltevreden, Former President of GBS, Novartis, and Atul Vashistha, CEO of Aokah
October 6, 2026
About the Report
The GCC Playbook for the Pharmaceutical Industry presents a CXO perspective on moving from transactional offshoring to intelligent, governed, AI orchestrated Global Capability Centers, examining the forces reshaping pharma and what industry leaders are doing differently. Structured across architecture choices, risk, financial blueprint, the 2027 to 2030 outlook, and a board level action framework.